Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04303702 · ClinicalTrials.gov registry record · NA

The Role of Oxytocin in the Second Stage of Labor

A NA study of Labor Complication, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT04303702: Recruiting NA study of Labor Complication, sponsored by Washington University School of Medicine.

NCT04303702 is a NA study of Labor Complication that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 400 participants, above the 237-participant average among 5 other Labor Complication trials with a reported enrollment target (69% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04303702, a NA study of Labor Complication, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

Primary Outcome

Time interval from complete cervical dilation to delivery of fetus

Conditions Studied

Interventions

  • DRUG Continue Oxytocin
  • OTHER Discontinue Oxytocin

Study Locations (1)

Missouri

  • Barnes Jewish Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-07-01
Est. Completion 2027-09-30
Phase NA

What NCT04303702 shows while recruiting

NCT04303702 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 237-participant average among 5 other Labor Complication trials with a reported enrollment target (69% higher).

The record links to 1 condition, with Labor Complication appearing as the primary indexed condition, and to 2 interventions - of which Continue Oxytocin is the first listed.

NCT04303702 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT04303702 about?

NCT04303702 is a clinical study titled "The Role of Oxytocin in the Second Stage of Labor". This is a randomized controlled trial investigating the utility of oxytocin administration in the second stage of labor.

What is the current status of trial NCT04303702?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-07-01. Estimated completion is 2027-09-30.

What conditions does trial NCT04303702 study?

This clinical trial studies the following conditions: Labor Complication.

What interventions are being tested in trial NCT04303702?

The interventions under investigation include: Continue Oxytocin (DRUG), Discontinue Oxytocin (OTHER).

Who is sponsoring clinical trial NCT04303702?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04303702 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Labor Complication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04303702, the US trial registry maintained by the National Library of Medicine. NCT04303702 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.